Deculin 15

Indonesia • Dexa Medica

Indication

Combination therapy
Deculin is indicated as a combination therapy with sulfonylurea or metformin in patients with type-2 diabetes mellitus who are inadequately controlled on sulfonylurea and metformin monotherapy.

Composition

Pioglitazone 15 mg

Package

5 strips of 6 tablets

Dosage Forms

Tablet

ATC Classification

A10B

Warning

Alcohol
Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
Caution
This item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.
Pregnancy
Not Recommended
This item is not safe for use during pregnancy.
Lactation
Not Recommended
This item is not safe for use during lactation.

Dosage

0 to 18 Years Old

No data are available of pioglitazone in children and adolescents under 18 years of age, therefore pioglitazone should not be used for that patients.

18 to 65 Years Old

Combination with metformin:
15-30 mg once daily. The current metformin dose can be continued upon initiation of pioglitazone therapy.

Combination with sulfonylurea:
15-30 mg once daily. The current sulfonylurea dose can be continued upon initiation of pioglitazone therapy. If hypoglycemia occurs, the dose of the sulfonylurea should be decreased. If hypoglycemia occurs, the dose of the sulfonylurea should be decreased.

65 Years Old and Above

No dose adjustment is necessary for elderly patients.

Administration

Should be taken once daily with or without food.

Patients with Impaired Renal Function

No dose adjustment is necessary in patients with renal failure (creatinine clearance >4 ml/minute).

Patients with Impaired Hepatic Function

Pioglitazone should not be used in patients with hepatic impairment.

See All Products